| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.828 | 14.420 | 7.375 | 8.091 | 4.931 | 972 | 0 | 1.419 | 0 | 0 |
| Total Income - EUR | 11.873 | 14.420 | 7.375 | 8.091 | 4.931 | 972 | 0 | 1.419 | 0 | 0 |
| Total Expenses - EUR | 10.856 | 11.485 | 3.642 | 1.622 | 1.409 | 53 | 168 | 167 | 0 | 232 |
| Gross Profit/Loss - EUR | 1.018 | 2.936 | 3.733 | 6.468 | 3.523 | 919 | -168 | 1.252 | 0 | -232 |
| Net Profit/Loss - EUR | 663 | 2.503 | 3.512 | 6.226 | 3.375 | 890 | -168 | 1.210 | 0 | -232 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Pro Salute Vera Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 580 | 2.675 | 3.694 | 6.415 | 5.487 | 6.222 | 2.619 | 1.189 | 0 | 2.655 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 1 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 0 | 1 |
| Cash | 580 | 2.674 | 3.694 | 6.413 | 5.486 | 6.220 | 2.617 | 1.187 | 0 | 2.653 |
| Shareholders Funds | 449 | 2.619 | 3.626 | 6.337 | 5.374 | 2.850 | 2.619 | 1.146 | 0 | 2.655 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 0 | 40 |
| Debts | 131 | 56 | 68 | 77 | 113 | 3.371 | 0 | 43 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8695 - 8695" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Pro Salute Vera Srl